Neil O'Neill Gilmore, CEO at Editas Medicine, Inc. (EDIT), sold 24,382 shares at $5.50 ($134K) on 2024-06-04, disclosed to the SEC on 2024-06-06.
Scheduled sale ($134k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.50 | 12,191 | $67K | 50.0% |
| 2 | $5.50 | 12,191 | $67K | 50.0% |
| Total | $5.50 avg | 24,382 | $134K | 100% |
| Filing → |
| EDIT | SELL | 2026-03-04 | $11K | — | Filing → |
| EDIT | SELL | 2025-12-04 | $12K | — | Filing → |
| EDIT | SELL | 2025-09-04 | $15K | — | Filing → |